EE63 Cost-Effectiveness of Olaparib Plus Bevacizumab First-Line Maintenance in Ovarian Cancer Alongside the PAOLA-1 Trial.
- Resource Type
- Article
- Authors
- Perrier, L.; Zarca, K.; Cadet, T.; Morelle, M.; Cropet, C.; Burges, A.; Cecere, S.C.; Palacio, I.; Polterauer, S.; Yoshida, H.; Vuylsteke, P.; Colombo, N.; Nøttrup, T.J.; Abdeddaim, C.; El-Balat, A.; Cinieri, S.; Herrero, A.; Kaminski, M.C.; Pujade-Lauraine, E.; Durand-Zaleski, I.
- Source
- Value in Health. 2023 Supplement, Vol. 26 Issue 12, pS61-S62. 2p.
- Subject
- Language
- ISSN
- 1098-3015